Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Drugs companies turning to combination products

Drugs companies turning to combination products

3rd November 2005

Pharmaceutical firms are turning to combination therapies in order to offset the threat from generics, according to a report from Research and Markets.

The company said that combination products, which deliver a fixed dose of what would have been available in separate forms before, help boost current brands as well as assisting patients comply with drug courses.

Research and Markets said that such therapies produce high yield for relatively low risk, protecting company’s revenues by producing new patents that cannot be copied by generic manufacturers.

Patents also appreciate the added convenience of not having to purchase additional drugs or obtain multiple prescriptions, allowing them to manage their drug intake more efficiently.

Combination therapies can be delivered in several forms. As well as well known drug-drug combinations, drug-device and drug-biological products can also add value for the consumer and the manufacturer.

Research and Market’s report covers the history of the combination market, as well as current US guidelines and regulations of the treatments. It also looks at the ways patients have had a role in developing the products, and discusses differing approaches taken by the industry.

track© Adfero Ltd

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.